Cornelius Jan Frederick, Kürten Katharina, Fischer Igor, Hänggi Daniel, Steiger Hans Jakob
Klinik für Neurochirurgie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany.
Klinik für Neurochirurgie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Germany.
World Neurosurg. 2016 Nov;95:315-321. doi: 10.1016/j.wneu.2016.08.014. Epub 2016 Aug 16.
We sought to analyze long-term outcome and quality of life after surgery of cerebral cavernomas (CCs) with special regard to localization (brainstem vs. nonbrainstem).
We conducted a retrospective study in a tertiary care center (2000-2010). Clinical charts were analyzed. Health-related quality of life (QoL) was evaluated with the Short Form-36 questionnaire.
The study included 60 patients (21 male, 39 female, mean age 39.8 years). The distribution was 67% supratentorial, 7% cerebellar, and 26% brainstem (BS). In the BS group, 87.5% had a preoperative deficit versus 18.2% in the nonbrainstem group (NBS). Operative neurologic morbidity was 31.3% for BS versus 11.4% for NBS. After mean follow-up of 43 months, neurologic status was better or the same as compared with the preoperative status in 75% of BS and all of NBS. SF-36 showed no significant differences between all cavernoma patients compared with a normative healthy population except for a better "pain" score. Subgroup analysis found the same results when comparing NBS with the normative population. Comparison of BS versus norm and NBS, respectively, showed worse scores for BS in physical but not mental health (P ≤ 0.01).
Clinical outcome was different depending on location: NBS recovered the same neurologic status as preoperatively and showed better QoL in physical health and lower working inability than BS. Surprisingly, there was no difference in mental health. Moreover, QoL of the operated cavernoma population after long-term follow-up did not differ from the norm. We conclude that surgery of cavernomas even in eloquent areas may result in favorable outcome and high patient satisfaction.
我们试图分析脑海绵状血管瘤(CCs)手术后的长期预后和生活质量,特别关注其位置(脑干与非脑干)。
我们在一家三级医疗中心进行了一项回顾性研究(2000 - 2010年)。分析临床病历。使用简短健康调查问卷(Short Form-36 questionnaire)评估与健康相关的生活质量(QoL)。
该研究纳入60例患者(男性21例,女性39例,平均年龄39.8岁)。分布情况为幕上67%,小脑7%,脑干(BS)26%。在脑干组中,87.5%术前有神经功能缺损,而非脑干组(NBS)为18.2%。脑干组手术相关神经并发症发生率为31.3%,非脑干组为11.4%。平均随访43个月后,75%的脑干组患者神经状态较术前改善或不变,非脑干组患者全部如此。除了“疼痛”评分较好外,与正常健康人群相比,所有海绵状血管瘤患者的SF - 36问卷结果无显著差异。亚组分析发现,非脑干组与正常人群比较时结果相同。分别将脑干组与正常人群及非脑干组比较,结果显示脑干组在身体健康方面得分较差,但心理健康方面无差异(P≤0.01)。
临床预后因位置而异:非脑干组恢复到术前相同的神经状态,且在身体健康方面生活质量更好,工作能力丧失情况低于脑干组。令人惊讶的是,心理健康方面无差异。此外,长期随访后接受手术的海绵状血管瘤患者的生活质量与正常人群无差异。我们得出结论,即使在功能区的海绵状血管瘤手术也可能带来良好的预后和较高的患者满意度。